The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's disease

被引:15
作者
Henderson, Michael X. [1 ]
Henrich, Martin T. [2 ,3 ,4 ]
Geibl, Fanni F. [2 ,3 ,4 ]
Oertel, Wolfgang H. [2 ]
Brundin, Patrik [1 ]
Surmeier, D. James [4 ]
机构
[1] Van Andel Inst, Parkinsons Dis Ctr, Dept Neurodegenerat Sci, Grand Rapids, MI 49503 USA
[2] Philipps Univ Marburg, Dept Neurol, D-35043 Marburg, Germany
[3] Philipps Univ Marburg, Dept Psychiat & Psychotherapy, D-35043 Marburg, Germany
[4] Northwestern Univ, Feinberg Sch Med, Dept Neurosci, Chicago, IL 60611 USA
关键词
Vulnerability; Neurodegeneration; Lewy pathology; Synaptic; Propagation; SNCA; MITOCHONDRIAL OXIDANT STRESS; LEWY BODY PATHOLOGY; SUBSTANTIA-NIGRA; DOPAMINERGIC-NEURONS; CALCIUM-ENTRY; INCLUSIONS; DEMENTIA; BODIES; TRANSPLANTATION; NEUROPATHOLOGY;
D O I
10.1016/j.nbd.2022.105687
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is the most common neurodegenerative movement disorder, and motor dysfunction has been attributed to loss of dopaminergic neurons. However, motor dysfunction is only one of many symptoms experienced by patients. A neuropathological hallmark of PD is intraneuronal protein aggregates called Lewy pathology (LP). Neuropathological staging studies have shown that dopaminergic neurons are only one of the many cell types prone to manifest LP. Progressive appearance of LP in multiple brain regions, as well as pe-ripheral nerves, has led to the popular hypothesis that LP and misfolded forms of one of its major components - alpha-synuclein (aSYN) - can spread through synaptically connected circuits. However, not all brain regions or neurons within connected circuits develop LP, suggesting that cell autonomous factors modulate the develop-ment of pathology. Here, we review studies about how LP develops and progressively engages additional brain regions. We focus on how connectivity constrains progression and discuss cell autonomous factors that drive pathology development. We propose a mixed model of cell autonomous factors and trans-synaptic spread as mediators of pathology progression and put forward this model as a framework for future experiments exploring PD pathophysiology.
引用
收藏
页数:9
相关论文
共 151 条
  • [1] Prevalence and characteristics of dementia in Parkinson disease - An 8-year prospective study
    Aarsland, D
    Andersen, K
    Larsen, JP
    Lolk, A
    Kragh-Sorensen, P
    [J]. ARCHIVES OF NEUROLOGY, 2003, 60 (03) : 387 - 392
  • [2] α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration
    Abdelmotilib, Hisham
    Maltbie, Tyler
    Delic, Vedad
    Liu, Zhiyong
    Hu, Xianzhen
    Fraser, Kyle B.
    Moehle, Mark S.
    Stoyka, Lindsay
    Anabtawi, Nadia
    Krendelchtchikova, Valentina
    Volpicelli-Daley, Laura A.
    West, Andrew
    [J]. NEUROBIOLOGY OF DISEASE, 2017, 105 : 84 - 98
  • [3] Tunneling nanotubes: A possible highway in the spreading of tau and other prion-like proteins in neurodegenerative diseases
    Abounit, Saida
    Wu, Jessica W.
    Duff, Karen
    Victoria, Guiliana Soraya
    Zurzolo, Chiara
    [J]. PRION, 2016, 10 (05) : 344 - 351
  • [4] α-Synuclein Amyloids Hijack Prion Protein to Gain Cell Entry, Facilitate Cell-to-Cell Spreading and Block Prion Replication
    Aulic, Suzana
    Masperone, Lara
    Narkiewicz, Joanna
    Isopi, Elisa
    Bistaffa, Edoardo
    Ambrosetti, Elena
    Pastore, Beatrice
    De Cecco, Elena
    Scaini, Denis
    Zago, Paola
    Moda, Fabio
    Tagliavini, Fabrizio
    Legname, Giuseppe
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [5] Beach TG, 2009, ACTA NEUROPATHOL, V117, P613, DOI [10.1007/s00401-009-0538-8, 10.1007/s00401-010-0664-3]
  • [6] High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease
    Bender, A
    Krishnan, KJ
    Morris, CM
    Taylor, GA
    Reeve, AK
    Perry, RH
    Jaros, E
    Hersheson, JS
    Betts, J
    Klopstock, T
    Taylor, RW
    Turnbull, DM
    [J]. NATURE GENETICS, 2006, 38 (05) : 515 - 517
  • [7] Iron metabolism in parkinsonian syndromes
    Berg, Daniela
    Hochstrasser, Helmine
    [J]. MOVEMENT DISORDERS, 2006, 21 (09) : 1299 - 1310
  • [8] Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms
    Bézard, E
    Boraud, T
    Bioulac, B
    Gross, CE
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 1999, 11 (06) : 2167 - 2170
  • [9] Upregulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys
    Bezard, E
    Ravenscroft, P
    Gross, CE
    Crossman, AR
    Brotchie, JM
    [J]. NEUROBIOLOGY OF DISEASE, 2001, 8 (02) : 343 - 350
  • [10] The Aging Astrocyte Transcriptome from Multiple Regions of the Mouse Brain
    Boisvert, Matthew M.
    Erikson, Galina A.
    Shokhirev, Maxim N.
    Allen, Nicola J.
    [J]. CELL REPORTS, 2018, 22 (01): : 269 - 285